Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Alda Birgisdóttir, Hulda Asbjörnsdottir, Elísabet Cook, David Gislason, Christer Jansson, Isleifur Olafsson, Thorarinn Gislason, Rain Jogi & Bjarni Thjodleifsson. (2006) Seroprevalence of Toxoplasma gondii in Sweden, Estonia and Iceland. Scandinavian Journal of Infectious Diseases 38:8, pages 625-631.
Read now
Read now
G. Leroux-Roels, E. Moreau, I. Desombere & A. Safary. (1996) Safety and Immunogenicity of a Combined Hepatitis A and Hepatitis B Vaccine in Young Healthy Adults. Scandinavian Journal of Gastroenterology 31:10, pages 1027-1031.
Read now
Read now
Articles from other publishers (10)
Paloma Carrillo-Santisteve, Lara Tavoschi, Ettore Severi, Sandro Bonfigli, Michael Edelstein, Emma Byström, Pierluigi Lopalco, Valeria Alfonsi, Roman Chilbek, Angela Dominguez, Emmanouil Galanakis, Denisa Janta, Mira Kojouharova, Jördis J Ott, Noele Nelson, Vassiliki Papaevangelou, Daniel Shouval, Ingrid Uhnoo & Vytautas Usonis. (2017) Seroprevalence and susceptibility to hepatitis A in the European Union and European Economic Area: a systematic review. The Lancet Infectious Diseases 17:10, pages e306-e319.
Crossref
Crossref
KH Jacobsen & JS Koopman. (2005) The effects of socioeconomic development on worldwide hepatitis A virus seroprevalence patterns. International Journal of Epidemiology 34:3, pages 600-609.
Crossref
Crossref
Allan Linneberg, Christian Østergaard, Michael Tvede, Leif Pervical Andersen, Niels Henrik Nielsen, Flemming Madsen, Lars Frølund, Asger Dirksen & Torben Jørgensen. (2003) IgG antibodies against microorganisms and atopic disease in Danish adults: The Copenhagen Allergy Study. Journal of Allergy and Clinical Immunology 111:4, pages 847-853.
Crossref
Crossref
. (2001) Changing epidemiology of hepatitis A and hepatitis E in urban and rural India (1982–98). Journal of Viral Hepatitis 8:4, pages 293-303.
Crossref
Crossref
Yuory V. Karetnyi, Ella Mendelson, Eli Shlyakhov, Eithan Rubinstein, Nina Golubev, Ruth Levin, Michael Sandler, Mordechai Schreiber, Uri Rubinstein, Ilan Shif, Rachel Handsher, Noemi Varsano & Baruch Modan. (2005) Prevalence of antibodies against hepatitis A virus among new immigrants in Israel. Journal of Medical Virology 46:1, pages 61-65.
Crossref
Crossref
H. Briem & A. Safary. (2005) Immunogenicity and safety in adults of hepatitis A virus vaccine administered as a single dose with a booster 6 months later. Journal of Medical Virology 44:4, pages 443-445.
Crossref
Crossref
B. H. Heng, K. T. Goh, S. Doraisingham & G. H. Quek. (2009) Prevalence of hepatitis A virus infection among sewage workers in Singapore. Epidemiology and Infection 113:1, pages 121-128.
Crossref
Crossref
Shigetoshi Fujiyama, Koichi Odoh, Izumi Kuramoto, Kyosuke Mizuno, Ryuichiro Tsurusaki & Tatsuo Sato. (1994) Current seroepidemiological status of hepatitis A with a comparison of antibody titers after infection and vaccination. Journal of Hepatology 21:4, pages 641-645.
Crossref
Crossref
D. R. Howell, C. J. Thompson & J. A. J. Barbara. (2008) Anti‐HAV prevalence in a U.K. urban blood donor population and the effect on human normal Ig provision. Transfusion Medicine 3:4, pages 285-289.
Crossref
Crossref
A. Baki, M. Aynaci & I. Köksal. (1993) Prevalence of antibody to hepatitis a virus among children in Trabzon, Turkey. Infection 21:2, pages 132-133.
Crossref
Crossref